Hepatitis C virus-induced reduction in miR-181a impairs CD4+ T-cell responses through overexpression of DUSP6

Hepatology

Volumn 61, Issue 4, 2015, Pages 1163-1173

  Li, Guang Y ^a   Zhou, Yun ^b   Ying, Ruo S ^c   Shi, Lei ^d   Cheng, Yong Q ^e   Ren, Jun P ^a   Griffin, Jeddidiah W D ^a   Jia, Zhan S ^b   Li, Chuan F ^a   Moorman, Jonathan P ^a,f   Yao, Zhi Q ^a,f  

^a East Tennessee State University   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Guangzhou Eighth People's Hospital   (China)

^d XI'AN JIAOTONG UNIVERSITY   (China)

^e BEIJING 302 HOSPITAL   (China)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; DUAL SPECIFICITY PHOSPHATASE 6; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MICRORNA; MICRORNA 181A; UNCLASSIFIED DRUG; DUSP6 PROTEIN, HUMAN; MIRN181 MICRORNA, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL PROLIFERATION ASSAY; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CULTURE; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSLATION; T CELL CULTURE; T LYMPHOCYTE ACTIVATION; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; HEPACIVIRUS; PHYSIOLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DUAL SPECIFICITY PHOSPHATASE 6; HEPACIVIRUS; HUMANS; MICRORNAS;

EID: 84925348727     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27634     Document Type: Article

References (39)

1. Park SH, Rehermann B. Immune responses to HCV and other hepatitis viruses. Immunity 2014;40:13-24.
2. Rosen HR. Emerging concepts in immunity to hepatitis C virus infection. J Clin Invest 2013;123:4121-4130.
3. Au JS, Pockros PJ. Novel therapeutic approaches for hepatitis C. Clin Pharmacol Ther 2014;95:78-88.
4. Manns MP1, von Hahn T. Novel therapies for hepatitis C-one pill fits all? Nat Rev Drug Discov 2013;12:595-610.
5. Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 2007;8:93-103.
6. Lee CH, Kim JH, Lee SW. The role of microRNAs in hepatitis C virus replication and related liver diseases. J Microbiol 2014;52:445-451.
7. Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X, et al. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology 2012;56:1631-1640.
8. Mukherjee A, Shrivastava S, Bhanja Chowdhury J, Ray R, Ray RB. Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression. J Virol 2014;88:7929-7940.
9. Estrabaud E, Lapalus M, Broët P, Appourchaux K, De Muynck S, Lada O, et al. Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C. J Virol 2014;88:6394-6402.
10. Li G, Yu M, Lee WW, Tsang M, Krishnan E, Weyand CM, et al. Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med 2012;18:1518-1524.
11. kip1 pathways: role in hepatitis B vaccine failure in individuals with hepatitis C virus infection. J Immunol 2014;192:649-657.
12. Zhang Y, Ma CJ, Ni L, Zhang CL, Wu XY, Kumaraguru U, et al. Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection. J Immunol 2011;186:3093-3103.
13. Wang JM, Shi L, Ma CJ, Ji XJ, Ying RS, Wu XY, et al. Differential regulation of IL-12/IL-23 by Tim-3 drives Th17 cell development during HCV infection. J Virol 2013;87(8):4372-4383.
14. + T cell responses by Listeria monocytogenes-infected dendritic cells in the context of Tim-3 blockade. PLoS One 2014;9(1):e87821.
15. Skalsky RL, Cullen BR. Viruses, microRNAs, and host interactions. Annu Rev Microbiol 2010;64:123-141.
16. Singaravelu R, Russell RS, Tyrrell DL, Pezacki JP. Hepatitis C virus and microRNAs: mired in a host of possibilities. 2014;7:1-10.
17. Wang JM, Ma CJ, Li GY, Wu XY, Thayer P, Greer P, et al. Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: role in hepatitis B vaccine failure during hepatitis C infection. Vaccine 2013;31:2238-2245.
18. + T cell responses. Vaccine 2011;29:3169-3176.
19. Yao ZQ, Nguyen DT, Hiotellis AI, Hahn YS. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J Immunol 2001;167(9):5264-5272.
20. Beld M, Penning M, McMorrow M, Gorgels J, van den Hoek A, Goudsmit J. Different hepatitis C virus (HCV) RNA load profiles following seroconversion among injecting drug users without correlation with HCV genotype and serum alanine aminotransferase levels. J Clin Microbiol 1998;36:872-877.
21. Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007;129:147-161.
22. Cannell IG, Kong YW, Bushell M. How do microRNAs regulate gene expression? Biochem Soc Trans 2008;36:1224-1231.
23. Jackson RJ, Standart N. How do microRNAs regulate gene expression? Sci STKE 2007;367:re1.
24. Molina G, Vogt A, Bakan A, Dai W, Queiroz de Oliveira P, Znosko W, et al. Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages. Nat Chem Biol 2009;5:680-687.
25. Yao ZQ, Moorman JP. Immune exhaustion and immune senescence-two distinct pathways for HBV vaccine failure during HCV and/or HIV infection. Arch Immunol Ther Exp 2013;61:193-201.
26. Moorman JP, Wang JM, Zhang Y, Ji XJ, Ma CJ, Wu XY, et al. Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection. J Immunol 2012;189:755-766.
27. Yao ZQ, Ni L, Zhang Y, Ma CJ, Zhang CL, Dong ZP, et al. Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin's lymphoma. Immunol Invest 2011;40:243-264.
28. Ni L, Ma CJ, Zhang Y, Nandakumar S, Zhang CL, Wu XY, et al. PD-1 modulates regulatory T cells and suppresses T-cell responses in HCV-associated lymphoma. Immunol Cell Biol 2011;89:535-539.
29. Frazier AD, Zhang CL, Ni L, Ma CJ, Zhang Y, Wu XY, et al. Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection. Viral Immunol 2010;23:487-495.
30. Li G, Li K, Lea AS, Li NL, Abdulla NE, Eltorky MA, et al. In situ hybridization for the detection of hepatitis C virus RNA in human liver tissue. J Viral Hepat 2013; 20:183-192.
31. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003;113:673-676.
32. Bartel DP. MicroRNA genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
33. Papapetrou EP1, Kovalovsky D, Beloeil L, Sant'angelo D, Sadelain M. Harnessing endogenous miR-181a to segregate transgenic antigen receptor expression in developing versus post-thymic T cells in murine hematopoietic chimeras. J Clin Invest 2009;119:157-168.
34. Bartel DP, Chen CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004;5:396-400.
35. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004;303:83-86.
36. Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis ML, Nervi C, et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005;123:819-831.
37. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet 2005;37:495-500.
38. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15-20.
39. Ferrando-Martínez S, Ruiz-Mateos E, Romero-Sánchez MC, Muñoz-Fernández MÁ, Viciana P, Genebat M, et al. HIV infection-related premature immunosenescence: high rates of immune exhaustion after short time infection. Curr HIV Res 2011;9:289-294.